Financials
- Market Capitalization 3.49 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
41.95
売上高対価格比率
8.46
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1543 | DNLI Denali Therapeutics Inc. - Common Stock | 23.27 USD | -2.06% | -5.98% | +1.84% | +43.91% | 3.72 B USD | ||
| 1553 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.85 USD | -2.16% | -4.32% | +6.37% | +71.95% | 3.68 B USD | ||
| 1596 | ABCL AbCellera Biologics Inc. - Common Shares | 11.28 USD | -1.74% | -7.69% | +97.89% | +177.83% | 3.46 B USD | ||
| 1620 | GPCR Structure Therapeutics Inc - American Depositary Shares | 47.13 USD | +2.66% | -5.27% | -1.81% | +76.25% | 3.36 B USD |